{"id":"W2030908978","doi":"10.2174/187152011796011109","title":"Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma","year":2011,"lang":"en","type":"review","venue":"Anti-Cancer Agents in Medicinal Chemistry","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Glypican 3; Hepatocellular carcinoma; Cancer research; Monoclonal antibody; Immunohistochemistry; Oncofetal antigen; Medicine; Pathology; Antibody; Biology; Immunology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001982638,0.0005164293,0.0009004376,0.001217635,0.0001857873,0.000474891,0.0004567459,0.0006017605,0.001795499],"category_scores_gemma":[0.0001346589,0.000170498,0.0003360707,0.0008211037,0.0001986568,0.0004584654,0.0003905938,0.0008495006,0.001257844],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003187462,"about_ca_system_score_gemma":0.0002749678,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006366935,"about_ca_topic_score_gemma":0.001391068,"domain_scores_codex":[0.9999431,0.00001128106,0.000005774019,0.000008523411,0.00002234217,0.000009002164],"domain_scores_gemma":[0.9999667,0.000009665088,0.000007558794,0.000001338607,0.00001005085,0.000004772143],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001564562,0.0002240436,0.0001864105,0.01059982,0.000113658,0.0007607222,0.00008371636,0.0008454924,0.02470652,0.00338543,0.01533812,0.9435997],"study_design_scores_gemma":[0.00007118802,0.0003412606,0.00149701,0.001200848,0.0001400182,0.003712757,0.00006188374,0.0004283242,0.008612512,0.001526644,0.9823762,0.00003127028],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00185079,0.99471,0.0003809464,0.0001998907,0.0001180937,0.00001460128,0.0000318897,0.00001566964,0.002678129],"genre_scores_gemma":[0.008666397,0.9880513,0.0005228714,0.0002185743,0.00008665257,0.00002059045,0.00007656913,0.000003359724,0.002353725],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001795499,"threshold_uncertainty_score":0.006006539,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1284621606049395,"score_gpt":0.3375057856867938,"score_spread":0.2090436250818543,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}